SYHA1803

N/A

Report date: 2026/04/05 20:00:15
NME

Base Information

Drug NameSYHA1803
Drug Alias NameSYHA-1803
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptors antagonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsSolid tumoursBiliary Tract NeoplasmsCarcinoma, Transitional Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursBiliary Tract NeoplasmsCarcinoma, Transitional Cell

Other Information

ATC CodeN/A
Related LinksN/A